NovaSom, an Obstructive Sleep Apnea (OSA) management company, announced recently that it has closed $35 million in equity financing. The investment was led by Safeguard Scientifics, as well as previous investors including TPG Biotechnology II Fund and Quaker BioVentures.
In a press release, the company stated their intent to use the funding for growth, expansion in payer and provider markets, and...
